The analysis of the levels of IL-6, IL-8, MIP-b1, and adipsin could be part of a biomarker panel for the diagnosis of ALS alongside the clinical and neurophysiological criteria. Here, CXCL8 is linked to amyotrophic lateral sclerosis.